Hemodiafiltration with on-line production of substitution fluid: long-term safety and quantitative assessment of efficacy

Contrib Nephrol. 1994;108:12-22. doi: 10.1159/000423354.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Bacteria / isolation & purification
  • Bicarbonates
  • Body Composition
  • Creatinine / blood
  • Disinfection
  • Drug Contamination
  • Equipment Contamination
  • Erythropoietin / therapeutic use
  • Evaluation Studies as Topic
  • Female
  • Hemodiafiltration / adverse effects
  • Hemodiafiltration / instrumentation
  • Hemodiafiltration / methods*
  • Hemodialysis Solutions
  • Humans
  • Immunologic Factors / therapeutic use
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / therapy
  • Male
  • Membranes, Artificial
  • Middle Aged
  • Prospective Studies
  • Recombinant Proteins / therapeutic use
  • Safety
  • Urea / blood
  • Water Microbiology

Substances

  • Antihypertensive Agents
  • Bicarbonates
  • Hemodialysis Solutions
  • Immunologic Factors
  • Membranes, Artificial
  • Recombinant Proteins
  • Erythropoietin
  • Urea
  • Creatinine